Uploaded October 2025 | Updated September 2026, 2 weeks ago
Cancer remains one of the most significant global health challenges of the Noncommunicale diseases era, with more than 35 million new cases expected annually by 2050. This World Health Summit 2025 session, co-hosted by Pfizer, explores how countries can shift from high-level ambition to real-world implementation.
Moderated by Allison Carlson (Foreign Policy) and Andrew Sollinger (Foreign Policy), the panel brings together leaders from government, global health, research, advocacy, and industry to examine the evolving global cancer landscape. The Speakers, Karin Tollefson (Pfizer), Dorothy Keefe (Cancer Australia), Cary Adams (UICC), Alarcos Cieza (WHO), Csaba L. Dégi (European Cancer Organization), Phoebe Ongadi (KENCO), and Tim Wintermantel (IQVIA) discuss what countries need to design, resource, and scale effective national cancer control plans. They highlight how stronger partnerships and coordinate action can drive equitable and sustainable cancer control worldwide.
The session showcases best practices for resilient health systems, the importance of robust financing and governance, and how innovation -from prevention and early detection to treatment and data-driven solutions-can accelerate progress toward global health goals and improve outcomes for all.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
Cancer remains one of the most significant global health challenges of the Noncommunicale diseases era, with more than 35 million new cases expected annually by 2050. This World Health Summit 2025 session, co-hosted by Pfizer, explores how countries can shift from high-level ambition to real-world implementation.
Moderated by Allison Carlson (Foreign Policy) and Andrew Sollinger (Foreign Policy), the panel brings together leaders from government, global health, research, advocacy, and industry to examine the evolving global cancer landscape. The Speakers, Karin Tollefson (Pfizer), Dorothy Keefe (Cancer Australia), Cary Adams (UICC), Alarcos Cieza (WHO), Csaba L. Dégi (European Cancer Organization), Phoebe Ongadi (KENCO), and Tim Wintermantel (IQVIA) discuss what countries need to design, resource, and scale effective national cancer control plans. They highlight how stronger partnerships and coordinate action can drive equitable and sustainable cancer control worldwide.
The session showcases best practices for resilient health systems, the importance of robust financing and governance, and how innovation -from prevention and early detection to treatment and data-driven solutions-can accelerate progress toward global health goals and improve outcomes for all.
The World Health Summit is the leading global platform bringing together science, politics, civil society, and the private sector to catalyze collaborative and innovative solutions for key health priorities. Learn more at www.worldhealthsummit.org.
